Liz Parrish is the Founder and CEO of BioViva Sciences USA Inc. BioViva is committed to extending healthy lifespans using gene therapy. Liz is known as “the woman who wants to genetically engineer you,” she is a humanitarian, entrepreneur, author and innovator and a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of gene therapy, she serves as a motivational speaker to the public at large for BioViva and the life sciences. She is actively involved in international educational media outreach and is a founding member of the International Longevity Alliance (ILA). She is a founding member of the American Longevity Alliance (ALA) a 501(c)(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular & regenerative medicine with the aim to get governments to consider aging a disease.
BioViva Sciences
Liz Parrish, the founder and CEO of BioViva, is patient zero of a gene therapy that rejuvenated her telomeres up to 33 years. Why do telomeres matter?
Liz Parrish received a dual gene therapy composed of follistatin and telomerase in 2015.
International Longevity Alliance
American Longevity Alliance
A forum for information and discussion promoting healthy extension of the human lifespan far beyond ordinarily understood limits. Acknowledging health as a human right and promoting an understanding of the ageing process as a medical condition requiring treatment. An affiliate of the International Longevity Alliance. A 501(c)(3) not for profit corporation.
